Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Fiber, total dietary - Prevotella intermedia |
👶
Resveratrol and its derivative pterostilbene ameliorate intestine injury in intrauterine growth-retarded weanling piglets by modulating redox status and gut microbiota. Journal of animal science and biotechnology (J Anim Sci Biotechnol ) Vol: 12 Issue 1 Pages: 70 Pub: 2021 Jun 10 Epub: 2021 Jun 10 Authors Chen Y , Zhang H , Chen Y , Jia P , Ji S , Zhang Y , Wang T , Html Article Publication |
| Fiber, total dietary - Prevotella intermedia |
👶
Review article: dietary fibre-microbiota interactions. Alimentary pharmacology & therapeutics (Aliment Pharmacol Ther ) Vol: 42 Issue 2 Pages: 158-79 Pub: 2015 Jul Epub: 2015 May 24 Authors Simpson HL , Campbell BJ , Html Article Publication |
| Fiber, total dietary - Prevotella intermedia |
👶
Balancing Herbal Medicine and Functional Food for Prevention and Treatment of Cardiometabolic Diseases through Modulating Gut Microbiota. Frontiers in microbiology (Front Microbiol ) Vol: 8 Issue Pages: 2146 Pub: 2017 Epub: 2017 Nov 8 Authors Lyu M , Wang YF , Fan GW , Wang XY , Xu SY , Zhu Y , Html Article Publication |
| Fiber, total dietary - Prevotella intermedia |
👶
Metatranscriptomic analyses of plant cell wall polysaccharide degradation by microorganisms in the cow rumen. Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 81 Issue 4 Pages: 1375-86 Pub: 2015 Feb Epub: Authors Dai X , Tian Y , Li J , Luo Y , Liu D , Zheng H , Wang J , Dong Z , Hu S , Huang L , Html Article Publication |
| Fiber, total dietary - Prevotella intermedia |
👶
Effect of grape pomace supplement on growth performance, gastrointestinal microbiota, and methane production in Tan lambs. Frontiers in microbiology (Front Microbiol ) Vol: 14 Issue Pages: 1264840 Pub: 2023 Epub: 2023 Sep 28 Authors Cheng X , Du X , Liang Y , Degen AA , Wu X , Ji K , Gao Q , Xin G , Cong H , Yang G , Html Article Publication |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
